Class action funding arrangements that siphon off large percentages for commissions and legal fees are “unsustainable”, Federal Court Justice Michael Lee said Monday.
Bannister Law has withdrawn from a class action it filed against Ford over allegedly defective Powershift transmissions following a dispute between the firm and the litigation funder that’s backing the case.
Cash Converters has reached a settlement on the eve of trial in one of two consumer class actions alleging it engaged in unconscionable conduct by imposing high interest rates on short-term loans.
Domino’s Pizza and Precision Tracking have reached a settlement on the eve of trial in a hard-fought battle by the US pizza giant to invalidate two of the Australian tech startup’s patents covering a GPS system that helps customers locate delivery drivers in real-time.
The managing director of litigation funder Vannin Capital lost a battle to dismiss a cross claim brought against him by rival LCM in a case alleging LCM has misapplied funds in its trust.
The litigation funder at the centre of a challenge by Westpac to the Federal Court’s power to make common fund orders faced a fiery judge in a tense exchange Friday, after it revealed it was weighing a bid to pause a class action against the bank until after the appeal.
A Federal Court judge on Friday called a request for particulars by Qantas “ridiculous”, during the first hearing in a case brought by mechanics alleging they weren’t pay allowances owed while working on assignment in Los Angeles.
Generic drug company Apotex has settled a patent infringement case brought by global pharmaceutical giant Lundbeck over its blockbuster antidepressant Lexapro.
ASIC has successfully opposed a Federal Court judge’s push to appoint an independent referee in its case against AMP Financial Planning over alleged insurance churning.
The High Court has dismissed the ACCC’s bid to appeal a Full Federal Court decision upholding a ruling that drug giant Pfizer did not misuse its market power in the months leading up to the expiration of the patent for its blockbuster cholesterol drug Lipitor.